MedPath

Effect of low dose epinephrine injection in reducing surgical complications in patients undergoing surgery for benign prostate enlargement.

Phase 2
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/09/036964
Lead Sponsor
AIIMS Bhubaneswar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with benign prostatic hyperplasia with any one of the following:

1. Lower urinary tract symptoms who had failed standard medical

therapy (alpha blockers, 5 alpha reductase inhibitors)

2. Recurrent urinary retention (drug-refractory)

3. Recurrent urinary tract infection

4. Recurrent hematuria

Exclusion Criteria

ASA Grade 3 or more.

1. Patients with congenital or acquired Hyper/ hypo coagulation disorders.

2. Patients with hematological malignancies.

3. Patients with decompensated chronic liver disease or renal impairment or other bleeding diathesis.

4. Patients with collagen vascular disease or other connective tissue disorders.

5. Patients with a history of thromboembolic disease.

6. Patients with history of arrhythmias

7. Patients with a history of acute coronary syndrome within the past 12 months

8. Patients with pheochromocytoma, thyrotoxicosis, glaucoma, or asthma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath